Based on our previous results that IL‐35 gene therapy could significantly alleviate the pathogenesis of K14‐VEGF‐A‐tg psoriasis mice 27, we further investigated whether IL‐35 recombinant protein shows therapeutic potential on K14‐VEGF‐A‐tg psoriasis mice. The gene discussed is VEGFA; the disease is psoriasis.